I.M.D. International Medical Devices S.p.A. (BIT:IMD)
Italy · Delayed Price · Currency is EUR 1.300
0.00 (0.00%)
At close: Jun 5, 2026
BIT:IMD Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 34.45 | 39.73 | 38.47 | 41.8 | 46.2 |
Other Revenue | 0.05 | 0.01 | 0.02 | 0.08 | 0.08 |
| 34.5 | 39.74 | 38.49 | 41.88 | 46.29 | |
Revenue Growth (YoY) | -13.19% | 3.26% | -8.09% | -9.53% | 1387.75% |
Cost of Revenue | 25.85 | 29.44 | 28.12 | 30.07 | 33.15 |
Gross Profit | 8.65 | 10.3 | 10.36 | 11.8 | 13.13 |
Selling, General & Admin | 6.25 | 6.45 | 5.99 | 5.95 | 5.78 |
Amortization of Goodwill & Intangibles | 0.44 | 0.39 | 0.43 | 0.25 | 0.28 |
Other Operating Expenses | 0.1 | 0.02 | 0.25 | 0.4 | 0.86 |
Operating Expenses | 7.12 | 7.12 | 6.99 | 6.93 | 7.35 |
Operating Income | 1.53 | 3.18 | 3.37 | 4.87 | 5.78 |
Interest Expense | -0.03 | -0.05 | -0.12 | -0.03 | -0.02 |
Interest & Investment Income | 0.09 | 0.17 | 0.13 | 0.01 | - |
Currency Exchange Gain (Loss) | 0.03 | -0.04 | 0.01 | -0.05 | -0.03 |
Other Non Operating Income (Expenses) | 0.18 | 0.17 | - | 0 | 0 |
EBT Excluding Unusual Items | 1.8 | 3.43 | 3.39 | 4.8 | 5.74 |
Gain (Loss) on Sale of Investments | -0.08 | -0.08 | - | - | -0.1 |
Gain (Loss) on Sale of Assets | 0 | -0.13 | -0.04 | 0 | 0.01 |
Other Unusual Items | 0.15 | 0.03 | 0.22 | 0.1 | 0.36 |
Pretax Income | 1.88 | 3.25 | 3.57 | 4.9 | 6.01 |
Income Tax Expense | 0.48 | 1.02 | 1.12 | 1.67 | 1.61 |
Earnings From Continuing Operations | 1.4 | 2.23 | 2.45 | 3.23 | 4.4 |
Net Income to Company | 1.4 | 2.23 | 2.45 | 3.23 | 4.4 |
Minority Interest in Earnings | - | - | -0.24 | -0.3 | -0.28 |
Net Income | 1.4 | 2.23 | 2.22 | 2.93 | 4.12 |
Net Income to Common | 1.4 | 2.23 | 2.22 | 2.93 | 4.12 |
Net Income Growth | -37.33% | 0.55% | -24.34% | -28.78% | 2716.00% |
Shares Outstanding (Basic) | 17 | 17 | 17 | - | - |
Shares Outstanding (Diluted) | 17 | 17 | 17 | - | - |
EPS (Basic) | 0.08 | 0.13 | 0.13 | - | - |
EPS (Diluted) | 0.08 | 0.13 | 0.13 | - | - |
EPS Growth | -37.33% | 0.56% | - | - | - |
Free Cash Flow | 2.09 | 7.82 | -1.57 | -5.2 | 3.2 |
Free Cash Flow Per Share | 0.12 | 0.45 | -0.09 | - | - |
Dividend Per Share | - | 0.100 | 0.060 | - | - |
Dividend Growth | - | 66.67% | - | - | - |
Gross Margin | 25.08% | 25.91% | 26.93% | 28.19% | 28.37% |
Operating Margin | 4.43% | 7.99% | 8.77% | 11.64% | 12.49% |
Profit Margin | 4.05% | 5.61% | 5.76% | 7.00% | 8.89% |
Free Cash Flow Margin | 6.07% | 19.68% | -4.09% | -12.42% | 6.92% |
EBITDA | 1.83 | 3.78 | 4 | 5.36 | 6.25 |
EBITDA Margin | 5.30% | 9.51% | 10.41% | 12.80% | 13.51% |
D&A For EBITDA | 0.3 | 0.6 | 0.63 | 0.49 | 0.47 |
EBIT | 1.53 | 3.18 | 3.37 | 4.87 | 5.78 |
EBIT Margin | 4.43% | 7.99% | 8.77% | 11.64% | 12.49% |
Effective Tax Rate | 25.65% | 31.36% | 31.31% | 34.03% | 26.83% |
Revenue as Reported | 34.23 | 39.96 | 38.71 | 42.57 | 0.65 |